We next assessed the frequency of double, and triple hit mutational events in APC. Of cancers with truncating APC mutations, 50% also harbored a second truncating mutation in APC. One cancer had three truncating mutations in APC. When we included missense mutations in the assessment of potential double hit events, this percentage rose to 54%. This evidence concerns the gene APC and cancer.